Cargando…
Affordability of essential medicine prices in Malaysia’s private health sector
BACKGROUND: The lack of price control in Malaysia has led to increased market competition, resulting in high medicine prices, notably in the private sector. This largely affects patients’ out-of-pocket expenses in the private sector. Although generic medicines are preferred due to affordability, the...
Autores principales: | Ahmad, Nur Sufiza, Islahudin, Farida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052935/ https://www.ncbi.nlm.nih.gov/pubmed/30038489 http://dx.doi.org/10.2147/PPA.S151603 |
Ejemplares similares
-
Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019) -
Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia
por: Sufiza Ahmad, Nur, et al.
Publicado: (2020) -
Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia
por: Ahmad, Nur Sufiza, et al.
Publicado: (2013) -
Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia
por: Ahmad, Nur Sufiza, et al.
Publicado: (2021) -
Factors associated with good glycemic control among patients with type 2 diabetes mellitus
por: Ahmad, Nur Sufiza, et al.
Publicado: (2013)